Computer-implemented methods for determining if actual defects are potentially systematic defects or potentially random defects

Information

  • Patent Grant
  • 7975245
  • Patent Number
    7,975,245
  • Date Filed
    Wednesday, August 20, 2008
    16 years ago
  • Date Issued
    Tuesday, July 5, 2011
    13 years ago
Abstract
Various computer-implemented methods for determining if actual defects are potentially systematic defects or potentially random defects are provided. One computer-implemented method for determining if actual defects are potentially systematic defects or potentially random defects includes comparing a number of actual defects in a group to a number of randomly generated defects in a group. The actual defects are detected on a wafer. A portion of a design on the wafer proximate a location of each of the actual defects in the group and each of the randomly generated defects in the group is substantially the same. The method also includes determining if the actual defects in the group are potentially systematic defects or potentially random defects based on results of the comparing step.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention generally relates to computer-implemented methods for determining if actual defects are potentially systematic defects or potentially random defects. Certain embodiments relate to determining if actual defects are potentially systematic defects or potentially random defects by comparing actual defects grouped by design to randomly generated defects grouped by design.


2. Description of the Related Art


The following description and examples are not admitted to be prior art by virtue of their inclusion in this section.


An integrated circuit (IC) design may be developed using a method or system such as electronic design automation (FDA), computer aided design (CAD), and other IC design software. Such methods and systems may also be used to generate a circuit pattern database from the IC design. The circuit pattern database includes data representing a plurality of layouts for various layers of the IC. Data in the circuit pattern database may, therefore, be used to determine layouts for a plurality of reticles. A layout of a reticle generally includes polygons that define features in a pattern on the reticle. Each reticle is used to fabricate one of the various layers of the IC. The layers of the IC may include, for example, a junction pattern in a semiconductor substrate, a gate dielectric pattern, a gate electrode pattern, a contact pattern in an interlevel dielectric, and an interconnect pattern on a metallization layer.


Fabricating semiconductor devices such as logic and memory devices typically includes processing a substrate such as a semiconductor wafer using a large number of semiconductor fabrication processes to form various features and multiple levels of the semiconductor devices. For example, lithography is a semiconductor fabrication process that involves transferring a pattern from a reticle to a resist arranged on a semiconductor wafer. Additional examples of semiconductor fabrication processes include, but are not limited to, chemical-mechanical polishing (CMP), etch, deposition, and ion implantation. Multiple semiconductor devices may be fabricated in an arrangement on a single semiconductor wafer and then separated into individual semiconductor devices.


Inspection processes are used at various steps during a semiconductor manufacturing process to detect defects on wafers to promote higher yield in the manufacturing process and thus higher profits. Inspection has always been an important part of fabricating semiconductor devices such as ICs. However, as the dimensions of semiconductor devices decrease, inspection becomes even more important to the successful manufacture of acceptable semiconductor devices because smaller defects can cause the devices to fail. For instance, as the dimensions of semiconductor devices decrease, detection of defects of decreasing size has become necessary since even relatively small defects may cause unwanted aberrations in the semiconductor devices.


As design rules shrink, however, semiconductor manufacturing processes may be operating closer to the limitations on the performance capability of the processes. In addition, smaller defects can have an impact on the electrical parameters of the device as the design rules shrink, which drives more sensitive inspections. Therefore, as design rules shrink, the population of potentially yield relevant defects detected by inspection grows dramatically. As a result, more and more defects may be detected on the wafers, and correcting the processes to eliminate all of the defects may be difficult and expensive. As such, determining which of the defects actually have an effect on the electrical parameters of the devices and the yield may allow process control methods to be focused on those defects while largely ignoring others. Furthermore, at smaller design rules, process induced failures may, in some cases, tend to be systematic. That is, process induced failures tend to fail at predetermined design patterns often repeated many times within the design. In addition, although defects are generally related to process and design interaction, process induced failures are defects that are created from the artifacts of process variation not necessarily due to weak design and process variations. Systematic defects are structurally repeating defects that still may be distributed at random locations spatially. Elimination of systematic, electrically relevant defects is important because eliminating such defects can have a significant overall impact on yield.


One currently used method for separating systematic and random defects uses repeater analysis. Another method for separating systematic and random defects relies upon a user-defined horizontal cut-line (or threshold) applied to a Pareto chart illustrating defects grouped by similarity between design clips. Groups that include a number of defects higher than this cut-line are defined to be potential systematic defects although, in general, systematic defects are not identified based on defect count alone. In particular, review of potential systematic defects is generally performed. However, such methods have a number of disadvantages. For example, such previously used methods require user intervention and judgment to determine the threshold. In addition, random defect groups are known to often have higher defect counts than defect counts of systematic defect groups. As such, these previously used methods may produce incorrect results by identifying groups of random defects as potential systematic defects. In addition, the Pareto chart cut-line based methods may not be effective for determining which defect bins include potentially systematic defects since, if it is assumed that all defects on a given wafer are random defects (i.e., a 0% systematic assumption), then the defect counts shown in a Pareto chart illustrating the results of design based grouping may report only the relative area of different circuit structures on the wafer.


Accordingly, it may be advantageous to develop computer-implemented methods for determining if defects are potentially systematic defects or potentially random defects, which can be performed without user intervention and judgment and have higher accuracy than currently used methods for differentiating between potentially systematic defects and potentially random defects.


SUMMARY OF THE INVENTION

The following description of various embodiments of computer-implemented methods is not to be construed in any way as limiting the subject matter of the appended claims.


One embodiment relates to a computer-implemented method for determining if actual defects are potentially systematic defects or potentially random defects. The method includes comparing a number of actual defects in a group to a number of randomly generated defects in a group. The actual defects are detected on a wafer. A portion of a design on the wafer proximate a location of each of the actual defects in the group and each of the randomly generated defects in the group is substantially the same. The method also includes determining if the actual defects in the group are potentially systematic defects or potentially random defects based on results of the comparing step.


In one embodiment, the comparing step includes comparing a Pareto chart generated for the actual defects to a Pareto chart generated for the randomly generated defects. In another embodiment, the comparing step includes determining a ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group.


In one embodiment, the portion of the design corresponds to a design clip. In another embodiment, the method is performed separately for different groups of actual defects detected on the wafer. In one such embodiment, a portion of the design on the wafer proximate a location of each of the actual defects in each of the different groups is substantially the same. In another embodiment, the method is performed separately for all groups of actual defects detected on the wafer. In one such embodiment, a portion of the design on the wafer proximate a location of each of the actual defects in each of all of the groups is substantially the same.


In one embodiment, the method is performed without user intervention. In some embodiments, the actual defects are detected by inspection of a layer on the wafer, and the randomly generated defects are generated once for an inspection recipe for the layer on the wafer and used for performing the method for defects detected on the layer of multiple wafers using the inspection recipe.


In one embodiment, the determining step includes determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not greater than the number of the randomly generated defects in the group.


In another embodiment, the determining step includes determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is statistically greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not statistically greater than the number of the randomly generated defects in the group.


In one embodiment, prior to the comparing step, the method includes normalizing the number of the randomly generated defects in the group to the number of the actual defects in the group based on total number of the actual defects detected on the wafer and total number of the randomly generated defects.


In another embodiment, the method includes comparing the number of the actual defects in the group to a number of different randomly generated defects in a different group. A portion of the design proximate the location of each of the actual defects in the group and a location of each of the different randomly generated defects in the different group is substantially the same. The randomly generated defects and the different randomly generated defects are separately generated. In some such embodiments, the determining step includes determining if the actual defects in the group are potentially systematic defects or potentially random defects based on the results of comparing the number of the actual defects in the group to the number of the randomly generated defects in the group and the number of the different randomly generated defects in the group.


Each of the steps of the method described above may be further performed as described herein. In addition, each of the embodiments of the method described above may include any other step(s) of any other method(s) described herein. Furthermore, each of the embodiments of the method described above may be performed by any of the systems described herein.


Another embodiment relates to a computer-implemented method for creating a set of groups of randomly generated defects for use in determining if groups of actual defects are potentially systematic defects or potentially random defects. The method includes randomly generating a set of defects at different locations across an area corresponding to an inspected area of at least a portion of a wafer. The method also includes binning the set of randomly generated defects into groups such that a portion of a design on the wafer proximate locations of the randomly generated defects in each of the groups is substantially the same. In addition, the method includes determining a number of the randomly generated defects in each of the groups. The numbers of the randomly generated defects in the groups can be compared to numbers of actual defects in corresponding groups to determine if the actual defects in the corresponding groups are potentially systematic defects or potentially random defects.


In one embodiment, the method is performed more than once to determine additional numbers for a different set of randomly generated defects. In one such embodiment, the numbers and the additional numbers can be compared to the numbers of the actual defects in the corresponding groups to determine if the actual defects in the corresponding groups are potentially systematic defects or potentially random defects. In another such embodiment, the method includes using the additional numbers to validate the randomly generating step.


In one embodiment, randomly generating the set of defects includes randomly generating the set of defects using stochastic simulation. In another embodiment, randomly generating the set of defects includes randomly generating the defects at locations arranged in a grid across the area. In an additional embodiment, randomly generating the set of defects includes randomly generating the defects at locations having a substantially uniform distribution across the area. In a further embodiment, randomly generating the set of defects is performed such that a frequency of the randomly generated defects in each of the groups is approximately equal to a frequency of the portion of the design proximate the locations of the randomly generated defects in each of the groups across the area.


In one embodiment, the inspected area of at least the portion of the wafer is approximately equal to an inspected area of a die on the wafer. In another embodiment, the method includes generating a Pareto chart for the set of randomly generated defects. In one such embodiment, the numbers of the randomly generated defects can be compared to the numbers of the actual defects in the corresponding groups by comparing the Pareto chart for the set of the randomly generated defects to a Pareto chart for the actual defects.


Each of the steps of the method described above may be further performed as described herein. In addition, each of the embodiments of the method described above may include any other step(s) of any other method(s) described herein. Furthermore, each of the embodiments of the method described above may be performed by any of the systems described herein.


An additional embodiment relates to a computer-implemented method for creating a normalized set of groups of randomly generated defects for use in determining if corresponding groups of actual defects are potentially systematic defects or potentially random defects. The method includes determining a total number of all actual defects detected on a layer of a wafer. The method also includes normalizing numbers of randomly generated defects in groups to numbers of the actual defects in corresponding groups based on the total number of all of the actual defects detected on the wafer. A portion of a design on the wafer proximate locations of the randomly generated defects in each of the groups is substantially the same. The normalized numbers of the randomly generated defects in the groups can be compared to numbers of the actual defects in the corresponding groups to determine if the corresponding groups of the actual defects are potentially systematic defects or potentially random defects.


Each of the steps of the method described above may be further performed as described herein. In addition, the embodiment of the method described above may include any other step(s) of any other method(s) described herein. Furthermore, the embodiment of the method described above may be performed by any of the systems described herein.





BRIEF DESCRIPTION OF THE DRAWINGS

Further advantages of the present invention may become apparent to those skilled in the art with the benefit of the following detailed description of the preferred embodiments and upon reference to the accompanying drawings in which:



FIG. 1 is a die map illustrating one example of die stacking results showing actual defects detected on a wafer;



FIG. 2 is a die map illustrating one example of results of one embodiment of randomly generating a set of defects at different locations across an area corresponding to an inspected area of at least a portion of a wafer;



FIG. 3 is a Pareto chart, configured and generated according to embodiments described herein, for a set of randomly generated defects;



FIG. 4 is a Pareto chart, configured and generated according to embodiments described herein, for actual defects detected on a wafer;



FIG. 5 is a Pareto chart, configured and generated according to embodiments described herein, showing results of comparing a Pareto chart generated for actual defects to a Pareto chart generated for randomly generated defects;



FIG. 6 is a Pareto chart, configured and generated according to embodiments described herein, showing results of comparing a Pareto chart generated for actual defects to two Pareto charts generated for two different sets of randomly generated defects; and



FIG. 7 is a schematic diagram illustrating a side view of one embodiment of a computer-readable medium that includes program instructions executable on a computer system for performing one or more embodiments of one or more computer-implemented methods described herein and one embodiment of a system configured to perform one or more computer-implemented methods described herein.





While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and may herein be described in detail. The drawings may not be to scale. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.


DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

As used herein, the term “actual defects” refers to actual defects detected on a wafer. Therefore, the term “actual defects” does not refer to actual defects that may be present on a wafer but have not been detected on the wafer.


As used herein, the term “wafer” generally refers to substrates formed of a semiconductor or non-semiconductor material. Examples of such a semiconductor or non-semiconductor material include, but are not limited to, monocrystalline silicon, gallium arsenide, and indium phosphide. Such substrates may be commonly found and/or processed in semiconductor fabrication facilities.


A wafer may include one or more layers formed upon a substrate. For example, such layers may include, but are not limited to, a resist, a dielectric material, a conductive material, and a semiconductive material. Many different types of such layers are known in the art, and the term wafer as used herein is intended to encompass a wafer including all types of such layers.


One or more layers formed on a wafer may be patterned or unpatterned. For example, a wafer may include a plurality of dies, each having repeatable patterned features. Formation and processing of such layers of material may ultimately result in completed devices. Many different types of devices such as integrated circuits (ICs) may be formed on a wafer, and the term wafer as used herein is intended to encompass a wafer on which any type of device known in the art is being fabricated.


Although embodiments are described herein with respect to wafers, it is to be understood that the embodiments may be used for another specimen such as a reticle, which may also be commonly referred to as a mask or a photomask. Many different types of reticles are known in the art, and the terms “reticle,” “mask,” and “photomask” as used herein are intended to encompass all types of reticles known in the art.


Turning now to the drawings, it is noted that the figures are not drawn to scale. In particular, the scale of some of the elements of the figures is greatly exaggerated to emphasize characteristics of the elements. It is also noted that the figures are not drawn to the same scale. Elements shown in more than one figure that may be similarly configured have been indicated using the same reference numerals.


In general, the embodiments described herein relate to differentiating between potentially systematic defects and potentially random defects. “Potentially systematic defects” are defined herein as actual defects in a group of defects (or a bin) that is likely to contain systematic defects as opposed to random defects (although whether or not the group contains systematic defects may be confirmed or determined more definitely using one or more other methods (e.g., defect review)). “Potentially random defects” are defined herein as actual defects in a group (or a bin) that is likely to contain random defects as opposed to systematic defects (although whether or not the group contains random defects may be confirmed or determined in a more definite manner using one or more other methods (e.g., defect review)).


One embodiment relates to a computer-implemented method for creating a set of groups of randomly generated defects for use in determining if groups of actual defects are potentially systematic defects or potentially random defects. The actual defects are defects detected on a wafer. In particular, the actual defects may be detected on a patterned wafer such that the defects can be grouped based on design as described further herein. The set of groups of randomly generated defects may be used to determine if groups of actual defects are potentially systematic defects or potentially random defects as described further herein. In particular, the set of groups of randomly generated defects may be used in embodiments of methods for determining if actual defects are potentially systematic defects or potentially random defects described further herein.


The method includes randomly generating a set of defects at different locations across an area corresponding to an inspected area of at least a portion of a wafer. For example, the set of defects may be randomly generated on the design representing the inspected portion of the wafer (i.e. the inspected area of a die×number of die inspected). In this manner, the randomly generated defects may be generated with substantially the same defect density as the detected defects. In one embodiment, randomly generating the set of defects includes randomly generating the set of defects using stochastic simulation (e.g., simulation that is nondeterministic in some manner, as opposed to being deterministic). For example, the randomly generated defects may be simulated using any appropriate stochastic simulation method, system, algorithm, technique, etc. (e.g., Monte Carlo simulation) In this manner, the set of randomly generated defects may include truly randomly generated defects.


In another embodiment, randomly generating the set of defects includes randomly generating the defects at locations arranged in a grid across the area. For example, the defects may be oriented in a regular grid across the area. In an additional embodiment, randomly generating the set of defects includes randomly generating the defects at locations having a substantially uniform distribution across the area. (Randomly generated defects oriented in a regular grid may also have a substantially uniform distribution across the area.) In some such embodiments, randomly generating the set of defects may include removing actual defects detected by inspection of a layer on a wafer from inspection results and replacing the actual defects with randomly generated defects so that the randomly generated defects are substantially uniformly distributed across the area. The inspection results may include any appropriate inspection results such as a KLARF, and the randomly generated set of defects may be stored in a different file (e.g., a different KLARF) in a similar file format. Therefore, the generated file may essentially be a snapshot of what results for random defects on the layer of the wafer should look like.


One example of inspection results generated by inspection of a layer on a wafer that may be used to randomly generate the set of defects is shown in FIG. 1. In particular, FIG. 1 shows die map 10 of die stacking results generated by inspecting a 65 nm polysilicon layer of a wafer. In particular, die map 10 shows locations of actual defects 12 detected in multiple dies on the polysilicon layer overlaid with one another by die stacking, Die stacking results may be generated in any suitable manner. The KLARF for die map 10 includes 10,000 defects. The KLARF for die map 10 was used to generate another KLARF for randomly generated defects by removing the actual defects detected by the inspection from die map 10 and replacing the actual defects with randomly generated defects so that the randomly generated defects are substantially uniformly distributed across the area. In particular, die map 10 was used to generate die map 14 shown in FIG. 2 that shows locations of randomly generated defects 16 across the area. Randomly generated defects 16 include 10,000 defects arranged in a 100 defect×100 defect grid (or two-dimensional array) across the area of the die on the layer of the wafer.


The defects in both KLARFs can be binned based on design as described further herein, and the numbers of actual and randomly generated defects in corresponding groups can be compared as described further herein to determine if each group of actual defects includes potentially systematic defects or potentially random defects. In this manner, the results of design based grouping for actual defects and randomly generated defects may be compared on a group by group basis to determine if groups of actual defects include potentially systematic defects or potentially random defects.


In a further embodiment, randomly generating the set of defects is performed such that a frequency of the randomly generated defects in each of the groups is approximately equal to a frequency of the portion of the design proximate the locations of the randomly generated defects in each of the groups across the area. For example, the defects may be randomly generated such that the randomly generated defects have a frequency that is approximately equal to the expected frequency of random defects for certain structures within the design. Although random defectivity can vary widely from wafer to wafer, the more frequently certain structures appear in the design the more random defects will in general be detected in the structures. In this manner, for portions of the design that appear across the wafer at a higher frequency, more defects may be randomly generated thereby better approximating the number of random defects that may be detected on a wafer in different portions of the design. As such, randomly generated defects may exhibit substantially the same distribution across a wafer as the distribution of design clips across the wafer thereby better approximating the distribution of random defects that may actually be detected on the wafer.


In some embodiments, the inspected area of at least the portion of the wafer is approximately equal to an inspected area of a die on the wafer. In this manner, the randomly generated defects do not have to be generated at different locations across an area corresponding to the inspected area of the entire wafer. Instead, the randomly generated defects may be generated for only a portion of the entire inspected area of the wafer (e.g., an inspected area of a die on the wafer), and the numbers of the randomly generated defects in each of the groups may be normalized as described further herein based on the total number of actual defects detected across the entire inspected area of the wafer, the portion of the entire inspected area for which the randomly generated defects were generated, and the entire inspected area of the wafer. In addition, instead of randomly generating defects across the wafer, the set of defects may be randomly generated across an inspected area of a die (which is equivalent to simulating across the wafer and then stacking the defects). Furthermore, the randomly generated defect counts can be normalized to match the detected defect count as described further herein.


The method also includes binning the set of randomly generated defects into groups such that a portion of a design on the wafer proximate locations of the randomly generated defects in each of the groups is substantially the same. In this manner, each of the groups of the randomly generated defects corresponds to a different portion of the design, and the randomly generated defects in each of the groups are located proximate substantially the same portion of the design. As such, the randomly generated defects may be separated into groups based on design (e.g., design clip). Binning the set of randomly generated defects into the groups based on design may be performed as described in commonly owned U.S. patent application Ser. No. 11/561,735 by Kulkarni et al. published as U.S. Patent Application Publication No. 2007/0156379 on Jul. 5, 2007 and Ser. No. 11/561,659 Zafar et al. published as U.S. Patent Application Publication No. 2007/0288219 on Dec. 13, 2007, both of which were filed on Nov. 20, 2006, and both of which are incorporated by reference as if fully set forth herein. The embodiments described herein may include any step(s) of any method(s) described in these patent applications.


The method further includes determining a number of the randomly generated defects in each of the groups. The numbers of the randomly generated defects in the groups can be compared to numbers of actual defects in corresponding groups to determine if the actual defects in the corresponding groups are potentially systematic defects or potentially random defects. The numbers (e.g., the defect counts) of the randomly generated defects in the groups can be determined in any suitable manner. The numbers of the randomly generated defects in the groups can be compared to the numbers of the actual defects in the corresponding groups according to any of the embodiments described herein. In addition, determining if the actual defects in the groups are potentially systematic defects or potentially random defects may be performed based on results of the comparison according to any of the embodiments described herein.


In one embodiment, the method includes generating a Pareto chart for the set of randomly generated defects. This “random Pareto chart” can be constructed using any of the randomly generated defects described herein (e.g., truly randomly generated defects or defects that are oriented in a regular grid across the area). For example, the set of randomly generated defects may be binned into different groups based on design (e.g., design clip) as described further herein, and a Pareto chart may be generated for the set of randomly generated defects using results of the binning. As such, all of the defects in any one of the groups will be located proximate to the same (or substantially the same) portion of the design. Therefore, the Pareto chart for the randomly generated defects will show the numbers of defects binned into different groups, each of which corresponds to a different portion of the design.


One embodiment of such a Pareto chart is shown in FIG. 3. In particular, as shown in FIG. 3, a Pareto chart generated for a set of randomly generated defects shows the GDS pattern group ID along the x axis and the defect count along the y axis. As such, the Pareto chart graphically illustrates the number of defects binned into each of the different groups, each of which corresponds to a different portion of the GDS pattern. In this manner, the numbers of the randomly generated defects and the numbers of the actual defects in corresponding groups can be compared as described further herein by comparing the Pareto chart for the set of the randomly generated defects to a Pareto chart for the actual defects. In particular, using the Pareto charts, numbers of randomly generated defects and actual defects in groups that have the same GDS pattern group ID, and therefore are corresponding groups, may be compared.


Multiple runs of randomly generating the set of defects may be performed to provide for a more statistically significant approximation of the total random distribution so from a limited sample. For example, in one embodiment, the method is performed more than once to determine additional numbers for a different set of randomly generated defects. The method may be performed more than once such that different sets of randomly generated defects may be separately randomly generated. Each of the different sets of the randomly generated defects may be randomly generated in the same or different manners (e.g., according to any of the embodiments described herein). The additional numbers for the different set of the randomly generated defects may be determined according to any of the embodiments described herein. The numbers and the additional numbers can be compared to the numbers of the actual defects in the corresponding groups to determine if the actual defects in the corresponding groups are potentially systematic defects or potentially random defects. The numbers for the different sets of the randomly generated defects in the groups can be compared to the numbers of the actual defects in the corresponding groups according to any of the embodiments described herein. In addition, determining if the actual defects in the corresponding groups are potentially systematic defects or potentially random defects may be performed based on the comparison to the numbers for the different sets of randomly generated defects according to any of the embodiments described herein. In some such embodiments, the method may include statistically combining results from multiple sets of randomly generated defects to determine the confidence interval for the count of each bin. This confidence interval can be used to assign a probability that a given bin is potentially systematic or could be used to set a threshold (e.g., bin as potentially systematic if count is greater than 90% confidence interval would indicate). In this manner, the randomly generating step may be statistically repeated to improve the confidence that the randomly generated population represents the actual population.


In another embodiment, the method is performed more than once to determine additional numbers for a different set of randomly generated defects, and the method includes using the additional numbers to validate the randomly generating step (in which the first set of randomly generated defects was generated). For example, the set of randomly generated defects (and the random Pareto chart) can be generated multiple times to validate the stability of the randomization process. In particular, the method may be performed more than once such that different sets of randomly generated defects are separately randomly generated. In this embodiment, each of the different sets of the randomly generated defects is preferably randomly generated in the same manner (e.g., according to any of the embodiments described herein). The additional numbers for the different set of the randomly generated defects may be determined according to any of the embodiments described herein. Validating the randomly generating step may include comparing the numbers for the different sets of randomly generated defects. The numbers for the different sets of the randomly generated defects in the groups can be compared on a group by group basis according to any of the embodiments described herein. In addition, validating the randomly generating step may include determining if the numbers for the different sets of randomly generated defects are similar enough to be considered statistically the same. Determining if the numbers are similar enough to be considered statistically the same may be performed in any appropriate manner.


The embodiments of the method described above may include any other step(s) of any other method(s) described herein. In addition, the embodiments of the method described above may be performed by any of the systems described herein.


Another embodiment relates to a computer-implemented method for creating a normalized set of groups of randomly generated defects for use in determining if corresponding groups of actual defects are potentially systematic defects or potentially random defects. The method includes determining a total number of all actual defects detected on a layer of a wafer. The actual defects included in the total number preferably do not include nuisance defects. In particular, nuisance defects are preferably removed from inspection results in any suitable manner prior to determining the total number. The actual defects may include defects detected on a layer of a patterned wafer. In addition, the method may or may not include detecting the actual defects on the layer of the wafer as described further herein. Furthermore, the method may or may not include removing the nuisance defects from the inspection results (e.g., if the wafer is inspected by another method, that method may include removing the nuisance defects from the inspection results and therefore the nuisance defects would not have to be removed from the inspection results by the methods described herein). Determining the total number of all of the actual defects detected on the layer may be performed in any suitable manner.


The method also includes normalizing numbers of randomly generated defects in groups to numbers of the actual defects in corresponding groups based on the total number of all of the actual defects detected on the wafer. A portion of a design on the wafer proximate locations of the randomly generated defects in each of the groups is substantially the same. Therefore, the randomly generated defects are grouped by design (e.g., by design clip), and the number of the randomly generated defects in each of the groups may be normalized based on total number of actual defects detected on the wafer. Normalizing the number of the randomly generated defects in each of the groups may be performed in any suitable manner (e.g., multiplying the number of randomly generated defects in each group by some factor so that the total number of randomly generated defects in all of the groups is approximately equal to the total number of actual defects detected on the wafer).


The total number of actual defects detected on the wafer may vary across wafers dramatically (e.g., due to variations in one or more processes used to fabricate the wafers and/or due to variations in the wafers themselves). As such, normalizing the number of the randomly generated defects in each of the groups may increase the accuracy with which potentially systematic defects can be differentiated from potentially random defects as described further herein. In addition, normalizing the number of the randomly generated defects in each of the groups based on the total number of actual defects detected on any given wafer increases the utility of the set of randomly generated defects (e.g., one set of randomly generated defects can be used for multiple wafers with relatively high accuracy regardless of the actual defectivity of different wafers). In addition, normalizing the number of randomly generated defects in each of the groups to defect density allows data to be compared from inspection recipe to inspection recipe for the same device. Such normalizing may be particularly advantageous for monitoring.


The normalized numbers of the randomly generated defects in the groups can be compared to numbers of the actual defects in the corresponding groups to determine if the corresponding groups of the actual defects are potentially systematic defects or potentially random defects. The normalized numbers of the randomly generated defects in the groups can be compared to the numbers of the actual defects in the corresponding groups according to any embodiments described herein. The results of such comparisons may be used to determine if the corresponding groups of the actual defects are potentially systematic defects or potentially random defects according to any embodiments described herein.


The embodiment of the method described above may include any other step(s) of any other method(s) described herein. In addition, the embodiment of the method described above may be performed by any of the systems described herein.


An additional embodiment relates to a computer-implemented method for determining if actual defects are potentially systematic defects or potentially random defects. The actual defects are detected on a wafer. In particular, the actual defects may be detected on a patterned wafer such that the actual defects may be grouped based on design as described further herein. The methods described herein may or may not include detecting the actual defects on the wafer. For example, the methods described herein may include inspecting the wafer using any suitable inspection method, system, and/or technique (e.g., by scanning the wafer with light, detecting light scattered from the wafer during the scanning, and detecting defects on the wafer using output responsive to the detected light). Alternatively, the methods described herein may include acquiring inspection results from another system (e.g., an inspection system), another method (e.g., a method performed to detect defects on the wafer), a storage medium (e.g., a fab database), etc.


A portion of a design on the wafer proximate a location of each of the actual defects in a group and each of the randomly generated defects in a corresponding group is substantially the same. In particular, the actual defects and the randomly generated defects may be binned into groups as described further herein based on a portion of a design proximate to the location of each of the defects. In this manner, the portion of the design proximate the locations of defects in a group may be substantially the same. In addition, different groups of actual defects correspond to different portions of the design, and different groups of randomly generated defects correspond to different portions of the design.


In one embodiment, the portion of the design corresponds to a design clip. The term “clip” as used herein refers to a relatively small portion of the design layout. For example, the term “clip” can be generally defined as the area in a design around a defect and can be thought of as the neighborhood of the defect. In addition, polygons define the pattern within the clip, but the polygons can partially extend beyond the clip. Therefore, each of the groups may correspond to a different portion of the design, and the different portions of the design may include different structures in the design. As such, the actual defects may be separated into groups based on design clip, and the randomly generated defects may be separated into groups based on design clip. In this manner, the numbers of the actual and randomly generated defects separated into groups corresponding to the same design clip may be compared as described further herein. In a similar manner, the actual and randomly generated defects may be separated into groups based on design using patch images of the defects. The patch images may be acquired in any suitable manner and may include any suitable such images. The actual and randomly generated defects may be separated into groups based on design (and design clip and/or patch images) as described in the above-referenced patent applications by Kulkarni et al. and Zafar et al., which are incorporated by reference as if fully set forth herein.


In some embodiments, prior to the comparing step described further herein, the method includes normalizing the number of the randomly generated defects in the group to the number of the actual defects in the group based on total number of the actual defects detected on the wafer and total number of the randomly generated defects. For example, the comparisons described further herein may be performed after a random Pareto chart has been normalized to a Pareto chart generated for the actual defects to account for differences in total defect count between the randomly generated defects and the actual defects. The number of the randomly generated defects in the group may be normalized to the number of the actual defects in a corresponding group according to any of the embodiments described herein.


The method includes comparing a number of actual defects in a group to a number of randomly generated defects in a group. In this manner, the method may include comparing an actual defect sample to a random defect sample. In addition, the number of actual defects in one group is compared to the number of randomly generated defects in a corresponding group. In particular, groups of actual defects and randomly generated defects that correspond to one another may include groups that include defects located proximate to the same (or substantially the same) portion of the design. In this manner, the number of actual defects located proximate to one portion of the design can be compared to the number of randomly generated defects located proximate to the same (or substantially the same) portion of the design. As such, the numbers of actual defects and randomly generated defects may be compared on a group basis and therefore a design basis. Comparing the numbers of the actual defects and the randomly generated defects in corresponding groups may be performed on a group basis according to any of the embodiments described herein.


In one embodiment, the comparing step includes comparing a Pareto chart generated for the actual defects to a Pareto chart generated for the randomly generated defects. In this manner, the comparing step may include comparing a distribution of randomly generated defects across pattern group to a distribution of actual defects across pattern group. In particular, the method may include comparing the design clip Pareto chart generated for the actual detected defects (actual Pareto chart) to a design clip Pareto chart generated for randomly generated defects (random Pareto chart).


One example of a Pareto chart generated according to embodiments described herein for actual defects is shown in FIG. 4. In particular, as shown in FIG. 4, the Pareto chart generated for the actual defects shows the GDS pattern group ID along the x axis and the defect count along the y axis. As such, the Pareto chart graphically illustrates the number of actual defects binned into each of the different groups, each of which corresponds to a different portion of the GDS pattern. Therefore, the Pareto chart illustrates the results of design based grouping performed for actual defects detected on a wafer.


In this manner, the numbers of the actual defects in groups can be compared to the numbers of the randomly generated defects in corresponding groups as described further herein by comparing the Pareto chart for the actual defects to a Pareto chart for the randomly generated defects. For example, corresponding groups of actual defects and randomly generated defects may be groups that have the same GDS pattern group ID. Therefore, groups of actual defects and randomly generated defects having the same GDS pattern group ID may be compared to each other to determine if any of the groups of actual defects are potentially systematic defects.



FIG. 5 illustrates one embodiment of results of comparison of a Pareto chart generated for actual defects to a Pareto chart generated for randomly generated defects. In particular, as shown in FIG. 5, the Pareto chart generated for a comparison of numbers of actual defects and randomly generated defects in corresponding groups shows the GDS pattern group ID along the x axis and the defect count for both the actual defects and the randomly generated defects along the y axis. As such, the Pareto chart shown in FIG. 5 graphically illustrates the numbers of actual defects and randomly generated defects binned into the different groups, each of which corresponds to a different portion of the GDS pattern.


In this manner, the Pareto chart shown in FIG. 5 shows how the numbers of the actual defects in different groups compare to the numbers of the randomly generated defects in corresponding groups. In this manner, the results of the comparison illustrated by the Pareto chart shown in FIG. 5 can be used to determine if groups of actual defects are potentially systematic defects or potentially random defects as described further herein. In particular, the actual defects binned into groups 2, 3, 4, and 10 may be determined to be potentially systematic defects based on the comparison results shown in the Pareto chart of FIG. 5 while the actual defects binned into groups 0, 5, 7, and 9 may be determined to be potentially random defects based on the comparison results shown in the Pareto chart of FIG. 5.


In another embodiment, the comparing step includes determining a ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group. The ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group may be determined in any suitable manner. In addition, the ratio may be a relative ratio, which may also be determined in any suitable manner. In this manner, the ratio of the number of actual defects to the number of randomly generated defects in groups corresponding to the same (or substantially the same) portion of the design may be determined, which provides a measure of the differences between the numbers of actual defects and randomly generated defects corresponding to the same (or substantially the same) portion of the design. Therefore, the ratio can be used to determine if groups of actual defects are potentially systematic defects or potentially random defects as described further herein.


The method also includes determining if the actual defects in the group are potentially systematic defects or potentially random defects based on results of the comparing step. For example, if there is a significant difference between the number of actual defects in a group and the number of randomly generated defects in a corresponding group, the actual defects in the group may be determined to be potentially systematic defects. A significant difference may be defined statistically (e.g., a significant difference may be a statistically significant difference). For example, almost all corresponding groups of actual and randomly generated defects may include different numbers of actual defects and randomly generated defects (e.g., due to natural variability in the processes performed on the wafers and/or due to natural variations in the wafers themselves). Therefore, the method may include determining if differences between numbers of actual defects and randomly generated defects in corresponding groups are statistically significant differences, which may be performed in any suitable manner.


In another example, the ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group, which may be determined as described above, may be used to determine if the actual defects in the group are likely to be systematic defects. For example, if the ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group is 1 or statistically close to 1, the actual defects in the group may be determined to be potentially random defects. However, if the ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group is statistically greater than 1, the actual defects in the group may be determined to be potentially systematic defects since systematic defect groups may be defect groups that have a relatively high ratio of actual defect count to randomly generated defect count. Determining if the ratio is statistically greater than 1 may be performed in any suitable manner.


The number of the randomly generated defects in the group that is used to determine the ratio may be the normalized number of randomly generated defects in the group since the randomly generated defects may be generated on a die basis while the number of the actual defects in the group will be wafer-based (e.g., based on the number of the actual defects detected across the wafer) or inspection plan-based (e.g., based on the area inspected on the wafer). Therefore, normalization may account for the different areas across which the randomly generated defects are generated and the actual defects are detected thereby increasing the accuracy of the determination of whether the actual defects are likely to be systematic defects.


Normalization may be performed as described further herein. Obviously, if the number of randomly generated defects in the group that is used to determine the ratio is the normalized number, such normalization would be performed before determining the ratio. Such normalization may also be performed before any other comparisons described herein. As described further herein, normalization may be performed because the total number of defects may be different. For example, a ratio of 1 (or any fixed number from run to run) may be used to identify potentially systematic defects unless the randomly generated defects and the actual defects have roughly the same number. In one such example, a population of randomly generated defects may be generated to have substantially the same count as a population of actual defects or a predetermined population of randomly generated defects may be normalized to the actual defects. Another way of looking at this is that the bins are normalized based on the total population counts for each of the populations so that we can compare them to each other.


In one embodiment, the determining step includes determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not greater than the number of the randomly generated defects in the group. For example, if the occurrence of a design clip group in an actual Pareto chart is significantly higher than the corresponding design clip group in the random Pareto chart, the design clip group of actual defects may be binned as potentially systematic. The numbers that are compared in such a determination may include absolute defect count or relative defect count. Potentially systematic defects may be identified in such a manner since systematic defects tend to occur more frequently than defects caused by chance alone. Therefore, if the number of actual defects in any group is significantly greater than the number of randomly generated defects in a corresponding group, then the actual defects in that group are likely systematic defects and can be determined as such by the embodiments described herein. In addition, such embodiments may include matching (or normalizing) the defects densities in both groups, which may be performed as described further herein. Such matching or normalizing may be advantageous since if there are two groups, group a and group b, and the number of defects in group b is low (e.g., due to lower capture rate), then the number of defects in group a will always be high enough to make it potentially systematic even though it may be potentially random.


In another embodiment, the determining step includes determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is statistically greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not statistically greater than the number of the randomly generated defects in the group. In this manner, the method may include statistically differentiating between potentially random and potentially systematic defects. As such, the methods may include statistically identifying marginalities in patterns in a design on a wafer. In particular, the method may include using statistical marginalities to identify potentially systematic defect bins by comparing them to a random distribution of defects. For example, the method may include performing a statistical test of the results of the comparison to determine if there is a significant difference between the actual defects in a group and the randomly generated defects in a corresponding group. If there is a significant difference, then the actual defects in the group may be determined to be potentially systematic defects. The numbers that are compared in such a determination may include absolute defect count or relative defect count.


In one embodiment, the method is performed separately for different groups of actual defects detected on the wafer, and a portion of the design on the wafer proximate a location of each of the actual defects in each of the different groups is substantially the same. For example, the actual and random Pareto charts may be compared as described further herein, and since the actual and random Pareto charts include defects separated into design based groups (e.g., design clip groups), the actual defects in each of the groups can be separately binned as likely including systematic defects or random defects by comparing the Pareto charts. The likely systematic design clip groups may be identified using results of comparison of the Pareto charts as described further herein.


In another embodiment, the method is performed separately for all groups of actual defects detected on the wafer, and a portion of the design on the wafer proximate a location of each of the actual defects in each of all of the groups is substantially the same. In this manner, the method can determine if potentially systematic defects occur anywhere on the Pareto chart generated for the actual defects. In addition, the method can substantially accurately identify potentially systematic defects that occur anywhere on the actual Pareto chart. For example, a Pareto chart may include thousands of different groups of defects binned based on design, but the embodiments described herein can easily, quickly, and substantially accurately determine if each of the thousands of different groups likely includes systematic or random defects. In this manner, the method does not need to know where in the Pareto chart (or which groups in the Pareto chart) to look for potentially systematic defects since all groups can be tested.


The method may also be performed separately for different regions on the wafer.


In a further embodiment, the method includes comparing the number of the actual defects in the group to a number of different randomly generated defects in a different group. A portion of the design proximate the location of each of the actual defects in the group and a location of each of the different randomly generated defects in the different group is substantially the same. The randomly generated defects and the different randomly generated defects are separately generated. In one such embodiment, the determining step includes determining if the actual defects in the group are potentially systematic defects or potentially random defects based on the results of comparing the number of the actual defects in the group to the number of the randomly generated defects in the group and the number of the different randomly generated defects in the group.


In this manner, the method may include comparing one group of actual defects to multiple groups of separately randomly generated defects to determine if the group of actual defects includes potentially systematic defects or potentially random defects. Such comparisons may be performed according to any of the embodiments described herein. For example, such comparisons may be performed using Pareto charts. One embodiment of a Pareto chart that shows results of comparing a Pareto chart generated for actual defects to two Pareto charts generated for two different sets of randomly generated defects is shown in FIG. 6. In particular, as shown in FIG. 6, the Pareto chart generated for a comparison of numbers of actual defects and two different sets of separately randomly generated defects shows the GDS pattern group ID along the x axis and the defect count for the actual defects and the different sets of the randomly generated defects along the y axis. As such, the Pareto chart graphically illustrates the number of actual defects and separately randomly generated defects binned into the different groups, each of which corresponds to a different portion of the GDS pattern. In this manner, the Pareto chart shown in FIG. 6 shows how the numbers of the actual defects in different groups compare to the numbers of the separately randomly generated defects in the corresponding groups.


The results of the comparison illustrated by the Pareto chart shown in FIG. 6 can, therefore, be used to determine if groups of actual defects are potentially systematic defects or potentially random defects as described further herein. In particular, the actual defects binned into groups 2, 3, 4, and 10 may be determined to be potentially systematic defects based on the comparison results show in the Pareto chart of FIG. 6 while the actual defects binned into groups 0, 5, 7, and 9 may be determined to be potentially random defects based on the comparison results shown in the Pareto chart of FIG. 6. Groups in the Pareto charts of FIGS. 5 and 6 that have the same ID correspond to the same portion of the design. Therefore, the results shown in FIG. 6 confirm the results shown in FIG. 5 thereby confirming the validity of using one set of randomly generated defects for discriminating between potentially systematic and potentially random defects detected on a wafer. In addition, although the numbers of the actual defects in different groups may be compared to numbers of different sets of randomly generated defects in corresponding groups as described above, the data for the different sets of randomly generated defects may be combined and then compared to the numbers of the actual defects in the different groups to improve the statistics.


In some embodiments, the actual defects are detected by inspection of a layer on the wafer, and the randomly generated defects are generated (and grouped) once for an inspection recipe for the layer on the wafer (since different inspection recipes may inspect different areas on the wafer) and used for performing the method for defects detected on the layer of multiple wafers using the inspection recipe. For example, a random Pareto chart can be generated once for a recipe and stored and used for a comparison each time that an inspection is performed for the layer of any wafer using the inspection recipe. The comparison that is performed each time that an inspection is performed for the layer of any wafer may be performed according to any embodiments described herein (e.g., including steps such as normalization of the randomly generated defects). In this manner, the method may be implemented each time a wafer is inspected using the inspection recipe and an actual defect design clip Pareto chart is generated. The random Pareto chart may be generated as described herein and used as described herein.


In another embodiment, the method is performed without user intervention. Since no user intervention is required, the method may be automated. In this manner, the method may be performed automatically. As such, the method provides an automated method for determining whether a given collection of defects grouped by design (e.g., design clip) is potentially systematic or potentially random in nature.


The embodiments described herein may be used in a number of different manners. For example, systematic discovery and monitoring using design based binning is not very good at distinguishing between bins that are potentially systematic and bins that are potentially random when defect count is used. One proposed method includes using simulated random defect design based grouping (DBG) bin distribution to determine which bins are potentially systematic. This method assumes constant capture rates between bins, which may be a substantially limiting assumption. Therefore, better ways to prioritize bins and determine cut-lines are desirable. Ideally, such methods are not sensitive to capture rate differences across bins.


The embodiments described herein, however, may be used for systematic discovery. In one such example, the bins determined to include potentially systematic defects may be prioritized from most likely to be systematic to least likely to be systematic. For example, the DBG groups can be prioritized by the ratio described further herein. In one such example, the Pareto chart can be re-charted based on ratio v. count. The higher the ratio, the more likely a group could be potentially systematic. The bins may then be reviewed in order of priority (from most likely to include systematic defects to least likely to include systematic defects).


In another example, the embodiments described herein may be used for monitoring. In particular, the embodiments described herein may be used for monitoring potentially systematic defects separately from potentially random defects. If the systematic count overall or within at least one bin gets too high, results can be used to hold the lot for engineering analysis (e.g., systematic discovery use case).


In another example, the methods described herein can be used in a design based classification (DBC) use case. DBC may be performed as described in the patent applications by Kulkarni et al. and Zafar et al., which are incorporated by reference above. For example, a wafer lot with a substantial number of random defects will increase the count in DBC bins, especially those bins with relatively high area across the wafer. Since it is unlikely that the defect counts of all DBC bins will increase proportionally except due to a random component, the total defect population may be examined to determine a best fit for random defects. Then, based on pattern of interest (POI) size, the defect density bin may be determined and compared with this random defect density. The DBC bin count can then be corrected based on random distribution.


In addition, if a POI or a set of POI is known not to have systematic defects, the defects detected in the POI or set of POI can be used as a surrogate or proxy to measure the random defect density. The random density may then be subtracted from the DBC bins and used to prioritize the DBG bins.


In some such examples, separating potentially systematic defect bins from potentially random defect bins may include setup to determine the equivalent area per most common DBG bins. Determining the equivalent area per most common DBG bins may include, at the time of recipe creation, dropping defects randomly in the inspected area to a predefined defect density, performing DBG, and for each bin, filtering out relatively low count bins (if there is a systematic signal on these patterns they will be easy to spot) and determining the equivalent area for that bin based on the count and the predefined defect density. For example, equivalent area for bin 1, EA1, may be determined as (Bin 1 count)/(defect density). The equivalent area information and “seed” clips may be stored with the recipe.


Setup may also include selecting a DBC bin for monitoring random defects. For example, a pattern or patterns of interest unlikely to have any systematic defects (e.g., blank clip or simple patterns) may be selected. These DBC bins can be used to monitor random defects. The effective area of the pattern may be determined from simulated data. For example, the area of the pattern plus a border to cover extending bounding box (EBB) may be determined. A design example may be marked for random monitoring, and the effective area (EAr) may be stored with DBC design examples.


Separating potentially systematic defect bins from potentially random defect bins may also include using DBC to estimate the random defect density during WPP. For example, using DBC to estimate the random defect density may include estimating the random defect density from the inspection defect count for this bin and the area. If there is a random defect excursion, it will be detected by the monitor. The monitor count may be used to estimate random defect density, DDr=(Inspection Bin, Count)/EAr). In addition, multiple monitors may be averaged.


Separating potentially systematic defect bins from potentially random defect bins may also include correcting DBC bin count. For example, if there is a random defect excursion, it will be detected by the monitor. As such, the monitor count may be used to determine the random defect density. For each DBC bin, the count may be converted to a to defect density based on the POI area plus EBB (e.g., DDn=(Binn Count)/(EAn)). For each DBC bin, the estimated random defect density may be subtracted to estimate the true systematic count (e.g., Binn Count)sys=(DDn−DDr)*(EAn)) for monitoring. Systematic bin counts greater than about 0 are potentially systematic. The higher the systematic bin count, the more likely the bin has a systematic issue.


Separating potentially systematic defect bins from potentially random defect bins may further include correcting DBG bin count. For example, for each DBG bin, the count may be converted to defect density using the equivalent area (e.g., DDn=(Binn Count)/(EAn)). The estimated random defect density (area based on the EBB) may then be subtracted. The result is presumably systematic defect count (e.g., (Binn Count)sys=(DDn−DDr)*(EAn)). Systematic bin counts greater than about 0 are potential systematic. The higher the systematic bin count, the more likely the bin has a systematic issue.


One significant advantage of such methods is that by using the DBC monitor, the capture rate of the random defect distribution can also be monitored and assuming it is truly random on the monitor, we can accurately subtract out these random defects. In particular, random defect correction is based on the measured random defect capture rate. It is much better to assume that the random defect capture rate is constant than the capture rate is constant between groups. The capture rate may still vary by pattern density. Since groups have different pattern densities on average, there still may be some inherent error. It might be possible to compensate if DBC bins spanning various pattern densities were monitored and bins were corrected with an interpolated DDr. Furthermore, auto-systematic threshold is advantageously dynamic based on the random monitor count.


In one embodiment, the results of the method (e.g., binned potentially systematic defects) may be used for analysis. The analysis may include any suitable analysis (e.g., analysis of the process and/or wafer).


All of the methods described herein may include storing results of one or more steps of the method embodiments in a storage medium. The results may include any of the results described herein and may be stored in any manner known in the art. The storage medium may include any storage medium described herein or any other suitable storage medium known in the art. After the results have been stored, the results can be accessed in the storage medium and used by any of the method or system embodiments described herein, formatted for display to a user, used by another software module, method, or system, etc. For example, after a method described above creates a set of groups of randomly generated defects, the method may include storing information about the set of the groups of the randomly generated defects in a storage medium. In addition, results or output of the embodiments described herein may be stored and accessed by an inspection system such that the inspection system can use the results (e.g., a Pareto chart for a set of randomly generated defects) to discriminate between potentially systematic and potentially random defects detected on a layer of a wafer. Furthermore, the results may be stored “permanently,” “semi-permanently,” temporarily, or for some period of time. For example, the storage medium may be random access memory RAM), and the results may not necessarily persist indefinitely in the storage medium.


Each of the embodiments of the method described above may include any other step(s) of any other method(s) described herein. In addition, each of the embodiments of the method described above may be performed by any of the systems described herein.


The embodiments described herein provide a number of advantages over other methods for determining if defects are potentially systematic defects or potentially random defects. For example, identifying potentially systematic and potentially random defects using the embodiments described herein can be performed without user intervention and judgment. In particulars no user intervention is required so the entire process can advantageously be automated (although the user may review the defects identified as potentially systematic and potentially random to determine which defects are actually systematic and/or random defects). In addition, the embodiments described herein have higher accuracy than currently used methods for differentiating between potentially systematic defects and potentially random defects. Furthermore, the methods can more accurately determine if potentially systematic defects occur anywhere on an actual defect Pareto chart. Therefore, the embodiments described herein can provide accuracy and automation for the identification of potentially systematic defects.


Another embodiment relates to a computer-readable medium that includes program instructions executable on a computer system for performing one or more computer-implemented methods described herein. One embodiment of such a computer-readable medium is shown in FIG. 7. In particular, computer-readable medium 18 includes program instructions 20 executable on computer system 22 for performing one or more of the computer-implemented methods described herein. In addition, the computer-implemented method executable on the computer system by the program instructions may include any step(s) of any method(s) described herein.


Program instructions 20 implementing methods such as those described herein may be transmitted over or stored on computer-readable medium 18. The computer-readable medium may be a transmission medium such as a wire, cable, or wireless transmission link. The computer-readable medium may also be a storage medium such as a read-only memory, a random access memory, a magnetic or optical disk, or a magnetic tape.


Computer system 22 may take various forms, including a personal computer system, mainframe computer system, workstation, image computer, parallel processor, or any other device known in the art. In general, the term “computer system” may be broadly defined to encompass any device having one or more processors, which executes instructions from a memory medium.


An additional embodiment relates to a system configured to perform one or more of the embodiments described herein. The system may include an inspection system configured to detect actual defects on a wafer. One embodiment of such a system is shown in FIG. 7. For example, as shown in FIG. 7, the system includes inspection system 24. Inspection system 24 is configured to detect actual defects on wafer 26.


In one embodiment, inspection system 24 includes light source 28. Light source 28 may include any appropriate light source known in the art. Light source 28 may be configured to direct light to beam splitter 30. Beam splitter 30 may be configured to direct light from light source 28 to wafer 26 at a substantially normal angle of incidence. Beam splitter 30 may include any appropriate optical component known in the art.


Light reflected from wafer 26 may pass through beam splitter 30 to detector 32. Detector 32 may include any appropriate detector known in the art. Output generated by detector 32 may be used to detect actual defects on wafer 26. For example, computer system 34 may be configured to detect actual defects on wafer 26 using output generated by the detector. The computer system may use any method and/or algorithm known in the art to detect actual defects on the wafer. The computer system may be coupled to the detector in any suitable manner (e.g., by one or more transmission media indicated by the dotted line shown in FIG. 7, which may include any suitable transmission media known in the art) such that the computer system can receive the output generated by the detector. Furthermore, if the inspection system includes more than one detector (not shown), the computer system may be coupled to each detector as described above. Computer system 34 may be further configured as described herein. During inspection, wafer 26 may be disposed on stage 36. Stage 36 may include any appropriate mechanical and/or robotic assembly known in the art. The inspection system shown in FIG. 7 may also include any other suitable components (not shown) known in the art.


As shown in FIG. 7, the inspection system is configured to detect light specularly reflected from the wafer. In this manner, the inspection system shown in FIG. 7 is configured as a BF inspection system. However, the inspection system may be replaced by an inspection system configured as a dark field (DF) inspection system, an edge contrast (EC) inspection system, an aperture mode inspection system, or any other optical inspection system known in the art. In addition, the inspection system may be configured to perform one or more inspection modes. For example, the inspection system shown in FIG. 7 may be configured to perform DF inspection by altering an angle of incidence at which the light is directed to the wafer and/or an angle at which light is collected from the wafer. In another example, the inspection system shown in FIG. 7 may be configured such that one or more optical components (not shown) such as apertures may be positioned in the illumination path and the collection path such that the inspection system can perform EC mode inspection and/or an aperture mode of inspection.


It is noted that FIG. 7 is provided herein to generally illustrate one configuration of an inspection system that may be included in the system embodiments described herein. Obviously, the inspection system configuration described herein may be altered to optimize the performance of the inspection system as is normally performed when designing a commercial inspection system. In addition, the systems described herein may be implemented using an existing inspection system (e.g., by adding functionality described herein to an existing inspection system) such as the Puma 9000 and 9100 series of tools that are commercially available from KLA-Tencor, San Jose, Calif. For some such systems, the methods described herein may be provided as optional functionality of the system (e.g., in addition to other functionality of the system). Alternatively, the system described herein may be designed “from scratch” to provide a completely new system.


In another embodiment, the optical inspection system shown in FIG. 7 may be replaced by an electron beam inspection system. Examples of commercially available electron beam inspection systems that may be included in the system of FIG. 7 include the eS25, eS30, and eS31 systems from KLA-Tencor.


Computer system 22 and/or computer system 34 may be configured to perform one or more of the computer-implemented method embodiments described herein (e.g., using inspection results generated by computer system 34). In embodiments of the system that include the inspection system, computer system 22 may be coupled to the inspection system in any manner known in the art. For example, computer system 22 may be coupled to computer system 34 of inspection system 24 such that the computer system can receive results of inspection generated by computer system 34. In addition, computer system 22 may receive any other output of the detector or computer system 34 such as image data and signals.


Computer system 22 described above may be configured as a stand-alone system that does not form part of a process, inspection, metrology, review, or other tool. In such an embodiment, computer system 22 may be configured to receive and/or acquire data or information from other systems (e.g., inspection results from an inspection system) by a transmission medium that may include “wired” and/or “wireless” portions. In this manner, the transmission medium may serve as a data link between the computer system and the other system. In addition, computer system 22 may send data to another system via the transmission medium. Such data may include, for example, one or more parameters of the inspection system to be used for inspection of the layer of additional wafers determined by the computer system. Alternatively, computer system 22 may form part of the inspection system. In some such embodiments, the system may include only one of the computer systems shown in FIG. 7, which is configured to perform defect detection and one or more of the embodiments described herein.


The embodiments of the system shown in FIG. 7 may be further configured as described herein. In addition, the system may be configured to perform any step(s) of any of the method embodiment(s) described herein.


Further modifications and alternative embodiments of various aspects of the invention may be apparent to those skilled in the art in view of this description. For example, computer-implemented methods for determining if actual defects are potentially systematic defects or potentially random defects are provided. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as the presently preferred embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.

Claims
  • 1. A computer-implemented method for determining if actual defects are potentially systematic defects or potentially random defects, comprising: comparing a number of actual defects in a group to a number of randomly generated defects in a group, wherein the actual defects are detected on a wafer, and wherein a portion of a design on the wafer proximate a location of each of the actual defects in the group and each of the randomly generated defects in the group is substantially the same; anddetermining if the actual defects in the group are potentially systematic defects or potentially random defects based on results of said comparing, wherein said determining comprises determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not greater than the number of the randomly generated defects in the group, and wherein said comparing and said determining are performed using a computer system.
  • 2. The method of claim 1, wherein said comparing comprises comparing a Pareto chart generated for the actual defects to a Pareto chart generated for the randomly generated defects.
  • 3. The method of claim 1, wherein said comparing comprises determining a ratio of the number of the actual defects in the group to the number of the randomly generated defects in the group.
  • 4. The method of claim 1, wherein the portion of the design corresponds to a design clip.
  • 5. The method of claim 1, wherein the method is performed separately for different groups of actual defects detected on the wafer, and wherein a portion of the design on the wafer proximate a location of each of the actual defects in each of the different groups is substantially the same.
  • 6. The method of claim 1, wherein the method is performed separately for all groups of actual defects detected on the wafer, and wherein a portion of the design on the wafer proximate a location of each of the actual defects in each of said all groups is substantially the same.
  • 7. The method of claim 1, wherein the method is performed without user intervention.
  • 8. The method of claim 1, wherein the actual defects are detected by inspection of a layer on the wafer, and wherein the randomly generated defects are generated once for an inspection recipe for the layer on the wafer and used for performing the method for defects detected on the layer of multiple wafers using the inspection recipe.
  • 9. The method of claim 1, wherein said determining further comprises determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is statistically greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not statistically greater than the number of the randomly generated defects in the group.
  • 10. The method of claim 1, wherein, prior to said comparing, the method further comprises normalizing the number of the randomly generated defects in the group to the number of the actual defects in the group based on total number of the actual defects detected on the wafer and total number of the randomly generated defects.
  • 11. The method of claim 1, further comprising comparing the number of the actual defects in the group to a number of different randomly generated defects in a different group, wherein a portion of the design proximate the location of each of the actual defects in the group and a location of each of the different randomly generated defects in the different group is substantially the same, wherein the randomly generated defects and the different randomly generated defects are separately generated, and wherein said determining further comprises determining if the actual defects in the group are potentially systematic defects or potentially random defects based on the results of said comparing the number of the actual defects in the group to the number of the randomly generated defects in the group and the number of the different randomly generated defects in the group.
  • 12. A non-transitory computer-readable medium, comprising program instructions executable on a computer system for performing a computer-implemented method for determining if actual defects are potentially systematic defects or potentially random defects, wherein the computer-implemented method comprises: comparing a number of actual defects in a group to a number of randomly generated defects in a group, wherein the actual defects are detected on a. wafer, and wherein a portion of a design on the wafer proximate a location of each of the actual defects in the group and each of the randomly generated detects in the group is substantially the same; anddetermining if the actual defects in the group are potentially systematic defects or potentially random defects based on results of said comparing, wherein said determining comprises determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not greater than the number of the randomly generated defects in the group.
  • 13. A system configured to determine if actual defects are potentially systematic defects or potentially random defects, comprising: an inspection system configured to detect actual defects on a wafer; anda computer system configured to: compare a number of the actual defects in a group to a number of randomly generated defects in a group, wherein a portion of a design on the wafer proximate a location of each of the actual defects in the group and each of the randomly generated defects in the group is substantially the same; anddetermine if the actual defects in the group are potentially systematic defects or potentially random defects based on results of the comparison, wherein determining if the actual defects in the group are potentially systematic defects or potentially random defects comprises determining that the actual defects in the group are potentially systematic defects if the number of the actual defects in the group is greater than the number of the randomly generated defects in the group and determining that the actual defects in the group are potentially random defects if the number of the actual defects in the group is not greater than the number of the randomly generated defects in the group.
PRIORITY CLAIM

This application claims priority to U.S. Provisional Application Nos. 60/956,823 entitled “Computer-Implemented Methods for Determining if Actual Defects are Systematic Defects or Random Defects,” filed Aug. 20, 2007, which is incorporated by reference as if fully set forth herein.

US Referenced Citations (354)
Number Name Date Kind
3495269 Mutschler et al. Feb 1970 A
3496352 Jugle Feb 1970 A
3909602 Micka Sep 1975 A
4015203 Verkuil Mar 1977 A
4247203 Levy et al. Jan 1981 A
4347001 Levy et al. Aug 1982 A
4378159 Galbraith Mar 1983 A
4448532 Joseph et al. May 1984 A
4532650 Wihl et al. Jul 1985 A
4555798 Broadbent, Jr. et al. Nov 1985 A
4578810 MacFarlane et al. Mar 1986 A
4579455 Levy et al. Apr 1986 A
4595289 Feldman et al. Jun 1986 A
4599558 Castellano et al. Jul 1986 A
4633504 Wihl Dec 1986 A
4641353 Kobayashi Feb 1987 A
4641967 Pecan Feb 1987 A
4734721 Boyer et al. Mar 1988 A
4758094 Wihl Jul 1988 A
4766324 Saadat et al. Aug 1988 A
4799175 Sano et al. Jan 1989 A
4805123 Specht et al. Feb 1989 A
4812756 Curtis et al. Mar 1989 A
4814829 Kosugi et al. Mar 1989 A
4817123 Sones et al. Mar 1989 A
4845558 Tsai et al. Jul 1989 A
4877326 Chadwick et al. Oct 1989 A
4926489 Danielson et al. May 1990 A
4928313 Leonard et al. May 1990 A
5046109 Fujimori et al. Sep 1991 A
5124927 Hopewell et al. Jun 1992 A
5189481 Jann et al. Feb 1993 A
5355212 Wells et al. Oct 1994 A
5444480 Sumita Aug 1995 A
5453844 George et al. Sep 1995 A
5481624 Kamon Jan 1996 A
5485091 Verkuil Jan 1996 A
5497381 O'Donoghue et al. Mar 1996 A
5528153 Taylor et al. Jun 1996 A
5544256 Brecher et al. Aug 1996 A
5563702 Emery et al. Oct 1996 A
5572598 Wihl et al. Nov 1996 A
5578821 Meisberger et al. Nov 1996 A
5594247 Verkuil et al. Jan 1997 A
5608538 Edger et al. Mar 1997 A
5619548 Koppel Apr 1997 A
5621519 Frost et al. Apr 1997 A
5644223 Verkuil Jul 1997 A
5650731 Fung Jul 1997 A
5661408 Kamieniecki et al. Aug 1997 A
5689614 Gronet et al. Nov 1997 A
5694478 Braier et al. Dec 1997 A
5696835 Hennessey et al. Dec 1997 A
5703969 Hennessey et al. Dec 1997 A
5737072 Emery et al. Apr 1998 A
5742658 Tiffin et al. Apr 1998 A
5754678 Hawthorne et al. May 1998 A
5767691 Verkuil Jun 1998 A
5767693 Verkuil Jun 1998 A
5771317 Edgar Jun 1998 A
5773989 Edelman et al. Jun 1998 A
5774179 Chevrette et al. Jun 1998 A
5795685 Liebmann et al. Aug 1998 A
5822218 Moosa et al. Oct 1998 A
5834941 Verkuil Nov 1998 A
5852232 Samsavar et al. Dec 1998 A
5866806 Samsavar et al. Feb 1999 A
5874733 Silver et al. Feb 1999 A
5884242 Meier et al. Mar 1999 A
5889593 Bareket Mar 1999 A
5917332 Chen et al. Jun 1999 A
5932377 Ferguson et al. Aug 1999 A
5940458 Suk Aug 1999 A
5948972 Samsavar et al. Sep 1999 A
5955661 Samsavar et al. Sep 1999 A
5965306 Mansfield et al. Oct 1999 A
5980187 Verhovsky Nov 1999 A
5986263 Hiroi et al. Nov 1999 A
5991699 Kulkarni et al. Nov 1999 A
5999003 Steffan et al. Dec 1999 A
6011404 Ma et al. Jan 2000 A
6014461 Hennessey et al. Jan 2000 A
6040912 Zika et al. Mar 2000 A
6052478 Wihl et al. Apr 2000 A
6060709 Verkuil et al. May 2000 A
6072320 Verkuil Jun 2000 A
6076465 Vacca et al. Jun 2000 A
6078738 Garza et al. Jun 2000 A
6091257 Verkuil et al. Jul 2000 A
6091846 Lin et al. Jul 2000 A
6097196 Verkuil et al. Aug 2000 A
6097887 Hardikar et al. Aug 2000 A
6104206 Verkuil Aug 2000 A
6104835 Han Aug 2000 A
6117598 Imai Sep 2000 A
6121783 Horner et al. Sep 2000 A
6122017 Taubman Sep 2000 A
6122046 Almogy Sep 2000 A
6137570 Chuang et al. Oct 2000 A
6141038 Young et al. Oct 2000 A
6146627 Muller Nov 2000 A
6171737 Phan et al. Jan 2001 B1
6175645 Elyasaf et al. Jan 2001 B1
6184929 Noda et al. Feb 2001 B1
6184976 Park et al. Feb 2001 B1
6191605 Miller et al. Feb 2001 B1
6201999 Jevtic Mar 2001 B1
6202029 Verkuil et al. Mar 2001 B1
6205239 Lin et al. Mar 2001 B1
6224638 Jevtic et al. May 2001 B1
6233719 Hardikar et al. May 2001 B1
6246787 Hennessey et al. Jun 2001 B1
6248485 Cuthbert Jun 2001 B1
6248486 Dirksen et al. Jun 2001 B1
6259960 Inokuchi Jul 2001 B1
6266437 Elchel et al. Jul 2001 B1
6267005 Samsavar et al. Jul 2001 B1
6268093 Kenan et al. Jul 2001 B1
6272236 Pierrat et al. Aug 2001 B1
6282309 Emery Aug 2001 B1
6292582 Lin et al. Sep 2001 B1
6324298 O'Dell et al. Nov 2001 B1
6344640 Rhoads Feb 2002 B1
6363166 Wihl et al. Mar 2002 B1
6373975 Bula et al. Apr 2002 B1
6388747 Nara et al. May 2002 B2
6393602 Atchison et al. May 2002 B1
6415421 Anderson et al. Jul 2002 B2
6445199 Satya et al. Sep 2002 B1
6451690 Matsumoto Sep 2002 B1
6459520 Takayama Oct 2002 B1
6466314 Lehman Oct 2002 B1
6466315 Karpol et al. Oct 2002 B1
6470489 Chang et al. Oct 2002 B1
6483938 Hennessey et al. Nov 2002 B1
6513151 Erhardt et al. Jan 2003 B1
6526164 Mansfield et al. Feb 2003 B1
6529621 Glasser et al. Mar 2003 B1
6535628 Smargiassi et al. Mar 2003 B2
6539106 Gallarda et al. Mar 2003 B1
6569691 Jastrzebski et al. May 2003 B1
6581193 McGhee et al. Jun 2003 B1
6593748 Halliyal et al. Jul 2003 B1
6597193 Lagowski et al. Jul 2003 B2
6602728 Liebmann et al. Aug 2003 B1
6608681 Tanaka et al. Aug 2003 B2
6614520 Baraket et al. Sep 2003 B1
6631511 Haffner Oct 2003 B2
6636301 Kvamme et al. Oct 2003 B1
6642066 Halliyal et al. Nov 2003 B1
6658640 Weed Dec 2003 B2
6665065 Phan et al. Dec 2003 B1
6670082 Liu et al. Dec 2003 B2
6680621 Savtchouk et al. Jan 2004 B2
6691052 Maurer Feb 2004 B1
6701004 Shykind et al. Mar 2004 B1
6718526 Eldredge et al. Apr 2004 B1
6721695 Chen et al. Apr 2004 B1
6734696 Horner et al. May 2004 B2
6738954 Allen et al. May 2004 B1
6748103 Glasser Jun 2004 B2
6751519 Satya et al. Jun 2004 B1
6753954 Chen Jun 2004 B2
6757645 Chang Jun 2004 B2
6759655 Nara et al. Jul 2004 B2
6771806 Satya et al. Aug 2004 B1
6775818 Taravade et al. Aug 2004 B2
6777147 Fonseca et al. Aug 2004 B1
6777676 Wang et al. Aug 2004 B1
6778695 Schellenberg et al. Aug 2004 B1
6779159 Yokoyama et al. Aug 2004 B2
6784446 Phan et al. Aug 2004 B1
6788400 Chen Sep 2004 B2
6789032 Barbour et al. Sep 2004 B2
6803554 Ye et al. Oct 2004 B2
6806456 Ye et al. Oct 2004 B1
6807503 Ye et al. Oct 2004 B2
6813572 Satya et al. Nov 2004 B2
6820028 Ye et al. Nov 2004 B2
6828542 Ye et al. Dec 2004 B2
6842225 Irie Jan 2005 B1
6859746 Stirton Feb 2005 B1
6879924 Ye et al. Apr 2005 B2
6882745 Brankner Apr 2005 B2
6884984 Ye et al. Apr 2005 B2
6886153 Bevis Apr 2005 B1
6892156 Ye et al. May 2005 B2
6902855 Peterson et al. Jun 2005 B2
6906305 Pease et al. Jun 2005 B2
6918101 Satya et al. Jul 2005 B1
6937753 O'Dell et al. Aug 2005 B1
6948141 Satya et al. Sep 2005 B1
6959255 Ye et al. Oct 2005 B2
6966047 Glasser Nov 2005 B1
6969837 Ye et al. Nov 2005 B2
6969864 Ye et al. Nov 2005 B2
6983060 Martinent-Catalot et al. Jan 2006 B1
6988045 Purdy Jan 2006 B2
7003755 Pang et al. Feb 2006 B2
7003758 Ye et al. Feb 2006 B2
7012438 Miller et al. Mar 2006 B1
7026615 Takane Apr 2006 B2
7027143 Stokowski et al. Apr 2006 B1
7030966 Hansen Apr 2006 B2
7030997 Neureuther et al. Apr 2006 B2
7053355 Ye et al. May 2006 B2
7061625 Hwang Jun 2006 B1
7071833 Nagano et al. Jul 2006 B2
7103484 Shi et al. Sep 2006 B1
7106895 Goldberg et al. Sep 2006 B1
7107517 Suzuki et al. Sep 2006 B1
7107571 Chang et al. Sep 2006 B2
7111277 Ye et al. Sep 2006 B2
7114142 Hanson et al. Sep 2006 B1
7114145 Ye et al. Sep 2006 B2
7117477 Ye et al. Oct 2006 B2
7117478 Ye et al. Oct 2006 B2
7120285 Spence Oct 2006 B1
7120895 Ye et al. Oct 2006 B2
7123356 Stokowski Oct 2006 B1
7124386 Smith Oct 2006 B2
7133548 Kenan et al. Nov 2006 B2
7135344 Nehmadi Nov 2006 B2
7136143 Smith Nov 2006 B2
7152215 Smith Dec 2006 B2
7162071 Hung et al. Jan 2007 B2
7171334 Gassner Jan 2007 B2
7174520 White Feb 2007 B2
7194709 Brankner Mar 2007 B2
7207017 Tabery et al. Apr 2007 B1
7231628 Pack et al. Jun 2007 B2
7236847 Marella Jun 2007 B2
7379175 Stokowski et al. May 2008 B1
7383156 Matsusita et al. Jun 2008 B2
7386839 Golender et al. Jun 2008 B1
7418124 Peterson et al. Aug 2008 B2
7424145 Horie et al. Sep 2008 B2
7676077 Kulkarni et al. Mar 2010 B2
7739064 Ryker et al. Jun 2010 B1
20010019625 Kenan et al. Sep 2001 A1
20010022858 Komiya et al. Sep 2001 A1
20010043735 Smargiassi et al. Nov 2001 A1
20020019729 Chang et al. Feb 2002 A1
20020026626 Randall et al. Feb 2002 A1
20020033449 Nakasuji et al. Mar 2002 A1
20020035461 Chang et al. Mar 2002 A1
20020035641 Kurose Mar 2002 A1
20020088951 Chen Jul 2002 A1
20020090746 Xu et al. Jul 2002 A1
20020134936 Matsui et al. Sep 2002 A1
20020144230 Rittman Oct 2002 A1
20020164065 Cai et al. Nov 2002 A1
20020176096 Sentoku et al. Nov 2002 A1
20020181756 Shibuya et al. Dec 2002 A1
20020186878 Hoon et al. Dec 2002 A1
20020192578 Tanaka et al. Dec 2002 A1
20030014146 Fujii Jan 2003 A1
20030017664 Pnueli et al. Jan 2003 A1
20030022401 Hamamatsu et al. Jan 2003 A1
20030033046 Yoshitake et al. Feb 2003 A1
20030048458 Mieher Mar 2003 A1
20030048939 Lehman Mar 2003 A1
20030057971 Nishiyama et al. Mar 2003 A1
20030086081 Lehman May 2003 A1
20030094572 Matsui et al. May 2003 A1
20030098805 Bizjak May 2003 A1
20030128870 Pease et al. Jul 2003 A1
20030138138 Vacca et al. Jul 2003 A1
20030138978 Tanaka et al. Jul 2003 A1
20030169916 Hayashi et al. Sep 2003 A1
20030192015 Liu Oct 2003 A1
20030207475 Nakasuji et al. Nov 2003 A1
20030223639 Shlain et al. Dec 2003 A1
20030226951 Ye et al. Dec 2003 A1
20030228714 Smith Dec 2003 A1
20030229410 Smith Dec 2003 A1
20030229412 White Dec 2003 A1
20030229868 White Dec 2003 A1
20030229875 Smith Dec 2003 A1
20030229880 White Dec 2003 A1
20030229881 White Dec 2003 A1
20030237064 White et al. Dec 2003 A1
20040030430 Matsuoka Feb 2004 A1
20040032908 Hagai et al. Feb 2004 A1
20040049722 Matsushita et al. Mar 2004 A1
20040052411 Qian et al. Mar 2004 A1
20040057611 Lee Mar 2004 A1
20040091142 Peterson et al. May 2004 A1
20040094762 Hess et al. May 2004 A1
20040098216 Ye et al. May 2004 A1
20040102934 Chang May 2004 A1
20040107412 Pack et al. Jun 2004 A1
20040119036 Ye et al. Jun 2004 A1
20040120569 Hung et al. Jun 2004 A1
20040133369 Pack et al. Jul 2004 A1
20040174506 Smith Sep 2004 A1
20040223639 Sato et al. Nov 2004 A1
20040228515 Okabe et al. Nov 2004 A1
20040234120 Honda et al. Nov 2004 A1
20040243320 Chang et al. Dec 2004 A1
20040254752 Wisniewski et al. Dec 2004 A1
20050004774 Volk et al. Jan 2005 A1
20050008218 O'Dell et al. Jan 2005 A1
20050010890 Nehmadi et al. Jan 2005 A1
20050062962 Fairley Mar 2005 A1
20050117796 Matsui Jun 2005 A1
20050132306 Smith Jun 2005 A1
20050141764 Tohyama et al. Jun 2005 A1
20050166174 Ye et al. Jul 2005 A1
20050184252 Ogawa et al. Aug 2005 A1
20050190957 Cai et al. Sep 2005 A1
20050198602 Brankner Sep 2005 A1
20060000964 Ye et al. Jan 2006 A1
20060048089 Schwarzbaned Mar 2006 A1
20060051682 Hess et al. Mar 2006 A1
20060062445 Verma et al. Mar 2006 A1
20060082763 The et al. Apr 2006 A1
20060159333 Ishikawa Jul 2006 A1
20060161452 Hess Jul 2006 A1
20060193506 Dorphan et al. Aug 2006 A1
20060193507 Sali et al. Aug 2006 A1
20060236294 Saidin Oct 2006 A1
20060236297 Melvin et al. Oct 2006 A1
20060239536 Shibuya Oct 2006 A1
20060265145 Huet et al. Nov 2006 A1
20060266243 Percin et al. Nov 2006 A1
20060269120 Nehmadi et al. Nov 2006 A1
20060273242 Hunsche et al. Dec 2006 A1
20060273266 Preil et al. Dec 2006 A1
20060291714 Wu et al. Dec 2006 A1
20060292463 Best et al. Dec 2006 A1
20070002322 Borodovsky et al. Jan 2007 A1
20070019171 Smith Jan 2007 A1
20070031745 Ye et al. Feb 2007 A1
20070032896 Ye et al. Feb 2007 A1
20070035322 Kang et al. Feb 2007 A1
20070035712 Gassner et al. Feb 2007 A1
20070035728 Kekare et al. Feb 2007 A1
20070052963 Orbon et al. Mar 2007 A1
20070064995 Oaki et al. Mar 2007 A1
20070133860 Lin Jun 2007 A1
20070156379 Kulkarni et al. Jul 2007 A1
20070230770 Kulkarni et al. Oct 2007 A1
20070248257 Bruce et al. Oct 2007 A1
20070280527 Almogy et al. Dec 2007 A1
20070288219 Zafar et al. Dec 2007 A1
20080013083 Kirk et al. Jan 2008 A1
20080049994 Rognin et al. Feb 2008 A1
20080072207 Verma et al. Mar 2008 A1
20080163140 Fouquet et al. Jul 2008 A1
20080167829 Park et al. Jul 2008 A1
20080250384 Duffy et al. Oct 2008 A1
20080295047 Nehmadi et al. Nov 2008 A1
20090210183 Rajski et al. Aug 2009 A1
Foreign Referenced Citations (31)
Number Date Country
0032197 Jul 1981 EP
0370322 May 1990 EP
1061358 Dec 2000 EP
1061571 Dec 2000 EP
1065567 Jan 2001 EP
1066925 Jan 2001 EP
1069609 Jan 2001 EP
1093017 Apr 2001 EP
1480034 Nov 2004 EP
1696270 Aug 2006 EP
2002-071575 Mar 2002 JP
2002-365235 Dec 2002 JP
2004-045066 Feb 2004 JP
1020030055848 Jul 2003 KR
1020050092053 Sep 2005 KR
WO 9857358 Dec 1998 WO
WO 9922310 May 1999 WO
WO 9925004 May 1999 WO
WO 9938002 Jul 1999 WO
WO 9941434 Aug 1999 WO
WO 9959200 Nov 1999 WO
WO 0003234 Jan 2000 WO
WO 0036525 Jun 2000 WO
WO 0055799 Sep 2000 WO
WO 0068884 Nov 2000 WO
WO 0070332 Nov 2000 WO
WO 0109566 Feb 2001 WO
WO 0140145 Jun 2001 WO
WO 03104921 Dec 2003 WO
WO 2004027684 Apr 2004 WO
WO 2006063268 Jun 2006 WO
Related Publications (1)
Number Date Country
20090055783 A1 Feb 2009 US
Provisional Applications (1)
Number Date Country
60956823 Aug 2007 US